Glatiramer Acetate | 合法藥品大搜索
Viatris'GlatiramerAcetateInjection,.anFDA-ApprovedtherapeuticequivalenttoCopaxone®.LearnMore.WhisperJECT®isavailablebyprescriptiononly.
MORE LESS
USEGLATIRAMER ACETATE INJECTION is a prescription medicine that is used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. It is not known if GLATIRAMER ACETATE INJECTION is safe and effective in children under 18 years of age.
IMPORTANT SAFETY INFORMATIONDo not take GLATIRAMER ACETATE INJECTION if you are allergic to glatiramer acetate or mannitol.
Serious side effects may happen right after or within minutes after you inject GLATIRAMER ACETATE INJECTION at any time during your course of treatment. Call your healthcare provider right away if you have any of these immediate post-injection reaction symptoms including redness to your cheeks or other parts of the body (flushing); chest pain; fast heartbeat; anxiety; breathing problems or tightness in your throat; or swelling, rash, hives, or itching. If you have symptoms ...
Glatiramer Acetate (Professional Patient Advice) | 合法藥品大搜索
Copaxone (Glatiramer Acetate) Side effects | 合法藥品大搜索
Copaxone (Glatiramer Acetate): Uses | 合法藥品大搜索
Glatiramer Injection | 合法藥品大搜索
Injecting Viatris' Glatiramer Acetate Injection with ... | 合法藥品大搜索
IMPORTANT SAFETY INFORMATION | 合法藥品大搜索
Viatris Advocate Co | 合法藥品大搜索
Glatiramer Acetate | 合法藥品大搜索
Patient Information Leaflet Glatiramer Acetate Injection (gla ... | 合法藥品大搜索
GLATIRAMER ACETATE | 合法藥品大搜索
【柯珮鬆注射液20毫克】Copaxone用於治療首次出現臨床症狀且有MRI為佐證之多發性硬化症病人。復發型多發性硬化症Copaxone,用於減少復發型多發性硬化病人的復發頻率。
藥品名稱:柯珮鬆注射液20毫克許可證字號:衛部罕藥輸字第000033號許可證種類:製 劑適應症:Copaxone用於治療首次出現臨床症狀...
【貝他費隆 注射劑】降低反覆發作型多發性硬化症的發作頻率及嚴重度。降低續發型多發性硬化症(secondary progressive multiple sclerosis)復發的頻率及嚴重度。發生單一臨床症狀(Clinically Isolated Syndrome)疑似多發性硬化症的病患,可延緩其惡化成多發性硬化症。
藥品名稱:貝他費隆 注射劑許可證字號:衛署菌疫輸字第000601號許可證種類:菌 疫適應症:降低反覆發作型多發性硬化症的發作頻...
【柯珮鬆注射液40毫克】用於復發型多發性硬化症,以減少復發型多發性硬化症病人的復發頻率。
藥品名稱:柯珮鬆注射液40毫克許可證字號:衛部罕藥輸字第000035號許可證種類:製 劑適應症:用於復發型多發性硬化症,以減少復...